Effect of Instrument-assisted Soft Tissue Mobilization on Functional and Cognitive Abilities in Elderly (IASTM-AGE)
Status
Conditions
Treatments
Details and patient eligibility
About
PURPOSE: To determine the effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly.
BACKGROUND: There is an increased interest in health care with growth of the older population.
Instrument-Assisted Soft Tissue Mobilization (IASTM) is a manual therapy technique using specially designed tools to apply pressure and mobilize soft tissues. It has gained attention as a non-invasive intervention that can aid in improving musculoskeletal health and overall function, especially in older adults. Given the aging population and the rise in age-related functional and cognitive decline, there is a pressing need for effective strategies to enhance quality of life in this demographic.
In the elderly, musculoskeletal issues, such as reduced muscle flexibility, joint stiffness, and soft tissue restrictions, are common and can severely impact physical function. IASTM has been shown to increase tissue perfusion, reduce fascial restrictions, and improve joint mobility. These effects are critical in countering age-related declines in mobility, balance, and overall physical functionality, ultimately promoting greater independence and reducing fall risk. Improved physical function through IASTM may also influence cognitive health positively, as increased physical activity and mobility are linked to better cognitive outcomes in the elderly.
HYPOTHESES: There will be no significant effect of Instrument-assisted soft tissue mobilization on functional and cognitive abilities in elderly.
RESEARCH QUESTION: Does instrument-assisted soft tissue mobilization is effective on functional and cognitive abilities in elderly?
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
60 elderly subjects aged range from 65-75 years old will participant in the study from both genders, had cognitive abilities to understand explanations and instructions, and did not take any medication that can affect their balance.
Exclusion criteria
they neither had sever musculoskeletal disorders nor neurological damage related to balance (dizziness, vestibular dysfunction), nor orthostatic hypotension, nor health risk factors.
Trial design
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Nouran Ahmed Ibrahim, lecturer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal